Dr. Shao-ping Li is a Distinguished Professor and Deputy Director at the State Key Laboratory of Quality Research in Chinese Medicine, Director of Joint Laboratory of Herbal Glycoengineering and Testing Technology, University of Macau, Member of Macau Talent Group Specializing in the Big Health Industry, Member of the Expert Advisory Committee for the Evaluation of Chinese Patent Medicines in Macau, and Head of Permanent Secretariat of West Pacific Reginal Forum for the Harmonization of Herbal Medicines (FHH), Editor of Journal of Pharmaceutical and Biomedical Analysis and International Journal of Analytical Chemistry, Executive Editor-in-Chief of Science of Traditional Chinese Medicine, Associate Editor of Frontiers in Pharmacology, Chinese Medicine, Chinese Journal of Pharmaceutical Analysis (藥物分析雜誌), Chinese Journal of Modern Applied Pharmacy (中國現代應用藥學) and Editorial Board member of Trends in Analytical Chemistry, Journal of Pharmaceutical Analysis, American Journal of Chinese Medicine, Acta Pharmaceutica Sinica A/B, etc. Dr. Li was selected in the Power List 2020 (Around the World in 60 Scientists) and 2021 (Around the World in 100 Scientists), as an expert in herbal glycoanalysis and the development of quality control methods for Chinese medicines, by Analytical Scientists. He is also an Expert Panel member of USP’s Herbal Medicines Compendium, Panel member of ISO standard for honey, Advisor of American Herbal Pharmacopoeia and member of Chinese Pharmacopoeia Commission.